C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/07/2002	WO2002032938A3 Regulation of human pgc-1-like protein
11/07/2002	WO2002030972A3 Regulation of nf-at interacting protein nip 45 like protein
11/07/2002	WO2002030971A3 Basb205 polypeptides and polynucleotides coding therefor
11/07/2002	WO2002030967A3 Novel compounds
11/07/2002	WO2002029064A3 Method for establishing germ cell-specific gene expression
11/07/2002	WO2002028897A3 Human g-protein coupled receptor and uses thereof
11/07/2002	WO2002024930A3 Artificial ubiquitous chromatin opening elements (ucoe)
11/07/2002	WO2002024927A3 Regulation of human adam-ts 1 precursor-like protein
11/07/2002	WO2002024886A3 Regulation of human serine protease
11/07/2002	WO2002024736A9 Polynucleotides and polypeptides associated with antibiotic biosynthesis and uses therefor
11/07/2002	WO2002024728A3 Mammalian nuclear receptor cofactor cf6 and methods of use
11/07/2002	WO2002020565A3 Collections of repeat proteins comprising repeat modules
11/07/2002	WO2002016586A3 Adenosine deaminase homolog
11/07/2002	WO2002016561A3 Mfq-111, a novel human gtpase like protein
11/07/2002	WO2002006458A3 Protease specific cleavable luciferases and methods of use thereof
11/07/2002	WO2002002600A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR27, AND USES THEROF
11/07/2002	WO2001098503A3 Regulation of human eosinophil serine protease 1-like enzyme
11/07/2002	WO2001092476A3 In vitro tissue test system
11/07/2002	WO2001092300A3 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level
11/07/2002	WO2001086002A9 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/07/2002	WO2001085768A9 G-protein coupled receptors and uses therefor
11/07/2002	WO2001075181A3 Method of identifying ginko biloba in a plant extract by gene profiling
11/07/2002	WO2001073056A3 Regulation of human oxoprolinase-like enzyme
11/07/2002	WO2001057086A9 Novel human g protein coupled receptor proteins and polynucleotides encoding the same
11/07/2002	WO2001053452A3 Regeneration and genetic transformation of acacia mangium
11/07/2002	WO2001048239A9 Screening method for nucleic acids
11/07/2002	WO2001048187A9 A molecular switch for regulating mammalian gene expression
11/07/2002	WO2001046408A9 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
11/07/2002	WO2001046406A9 New qtl's on chromosomes x, 2, 6 and 7 of pigs
11/07/2002	WO2001045493A3 Transcription factor stress-related proteins and methods of use in plants
11/07/2002	WO2001037881A9 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides
11/07/2002	WO2001037859A3 Pharmaceutical compositions containing compounds which increase or decrease tmtnf levels
11/07/2002	WO2001029240A9 Regeneration
11/07/2002	WO2001026676A9 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1)
11/07/2002	WO2001020035A9 Methods and compositions for linear isothermal amplification of polynucleotide sequences
11/07/2002	WO2001020034A9 Methods and compositions for the screening of cell cycle modulators
11/07/2002	WO2001018218A9 Expression of proteins in genetically modified fungi
11/07/2002	WO2001018045A9 Crystal structure of a deacetylase and inhibitors thereof
11/07/2002	WO2001018020A9 A eukaryotic mechanosensory transduction channel
11/07/2002	US20020166149 Sustained totipotent regenerable tissue culture of Arundo donax (Giant Reed) and totipotent tissue and plants produced therefrom
11/07/2002	US20020166146 Maize PR1 polynucleotides and methods of use
11/07/2002	US20020166145 Coffee mannanase
11/07/2002	US20020166144 Nucleotide sequences coding polypeptide for us einthe generation of preferential coatings, resins, glues, plastics, surfactants and lubricants
11/07/2002	US20020166143 Nucleotide sequences coding plypeptide for use in the generation of disease resistant plants
11/07/2002	US20020166142 Pathogen-resistant plants and method for production thereof
11/07/2002	US20020166141 Antimicrobial peptides and methods of use
11/07/2002	US20020166140 Mutated barnase gene and plant transformed by the same
11/07/2002	US20020166139 Methods for enhancing a plant stress response
11/07/2002	US20020166138 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
11/07/2002	US20020166137 LKB1 gene knockout animals
11/07/2002	US20020166136 Anti-inflammatory therapies using cytokine signaling regulated by a SOCS-3 promoter
11/07/2002	US20020166135 Modulation of preferential aspects of nervous system; obtain human, administer modulator, monitor expression of preferential neuropeptides in brain
11/07/2002	US20020166134 Cardiomyocytes with enhanced proliferative potenial, and methods for preparing and using same
11/07/2002	US20020166132 System for regulating in vivo the expression of a transgene by conditional inhibition
11/07/2002	US20020166131 Nucleotide sequences coding polypeptide for use in the treatment of disease parkinson's, irritable bowel syndrome and cardiovascular disorders
11/07/2002	US20020166130 Expression of active human factor IX in mammary tissue of transgenic animals
11/07/2002	US20020165481 Electrode apparatus and method for the delivery of drugs and genes into tissue
11/07/2002	US20020165388 Contacting DNA or RNA with hydrogen peroxide and radical generating coordination complexes for a time and concentrations to produce aldehydes, reacting with an amine to produce a condensation product and labeling
11/07/2002	US20020165386 C-junction-n-terminal kinase (JNK); microbiocides; treating neurodegenerative diseases
11/07/2002	US20020165385 Plastidic phosphoglucomutase genes
11/07/2002	US20020165383 Tenebrio antifreeze proteins
11/07/2002	US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor
11/07/2002	US20020165379 An isolated nucleic acid encoding a monomer of a calcium-activated potassium channel, and the monomer having molecular weight 40-80 kDa, unit conductance 2-6-pS, binding to antibodies generated against specific peptide sequence
11/07/2002	US20020165378 Human membrane antigen tm4 superfamily protein and dna encoding this protein
11/07/2002	US20020165377 ADAM polynucleotides, polypeptides, and antibodies
11/07/2002	US20020165374 Secreted protein HFEAF41
11/07/2002	US20020165373 Contacting the sample with an isolated recombinant immunodominant Neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex
11/07/2002	US20020165370 Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector
11/07/2002	US20020165367 Separation of glycosylated and nonglycosylated proteins; generate matrix with immobilized triazine dye, incubate with protein mix, wash, elute proteins, recover preferential proteins
11/07/2002	US20020165363 Cachexia remedy
11/07/2002	US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders
11/07/2002	US20020165358 Tumor cytotoxic factor for use in the treatment of cell proliferative and liver disorders
11/07/2002	US20020165357 38554, 57301 and 58324, human organic ion transporters and uses therefor
11/07/2002	US20020165356 Zinc finger binding domains for nucleotide sequence ANN
11/07/2002	US20020165355 Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
11/07/2002	US20020165353 Transport protein for use in human therapeutics and diagnostics
11/07/2002	US20020165352 Protein complex for use in the diagnosis and treatment of diabetes and nervous system disorders
11/07/2002	US20020165351 Novel compounds
11/07/2002	US20020165349 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system disorder and alzheimer's disease
11/07/2002	US20020165348 Human cytokine receptor
11/07/2002	US20020165347 Polypeptide for use in the diagnosis, prevention and treatment of arteriosclerosis and vascular restenosis
11/07/2002	US20020165346 Isolated mammalian membrane protein genes; related reagents
11/07/2002	US20020165208 Administering testosterone inhibitor; polypeptide
11/07/2002	US20020165196 Oligonucleotide inhibitors of cancer cell proliferation
11/07/2002	US20020165195 Method of treating androgen-dependent disorders
11/07/2002	US20020165194 Method for selective inactivation of viral replication
11/07/2002	US20020165192 Grafting bone marrow; using inositol polyphosphatase; antigen for blocking gene expression
11/07/2002	US20020165191 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
11/07/2002	US20020165190 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same
11/07/2002	US20020165189 Oligoribonucleotides and ribonucleases for cleaving RNA
11/07/2002	US20020165187 Isolated nucleic acids; therapy, diagnosis
11/07/2002	US20020165186 Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/07/2002	US20020165184 Forming a polymer in the presence of a biologically active drug for delivery to a cell; cationic polyamine compounds for conjugation with polyethylene glycol and complexing with nucleic acids
11/07/2002	US20020165181 Oligonucleotides which contain region(s) of 2'-modified nucleosides connected by alternating phosphodiester and phosphorothioate linkages; use as antisense agents, assaying a nucleic acid; nuclease resistant
11/07/2002	US20020165177 Modified factor VIII cDNA
11/07/2002	US20020165175 Fast and enzymeless cloning of nucleic acid fragments
11/07/2002	US20020165174 Methods and compositions for antisense VEGF oligonucleotides
11/07/2002	US20020165173 T-cell factor (TCF); constructs having multiple repeats of a TCF-binding element linked to a promoter and used to express genes encoding therapeutic proteins; drug screening for anticancer agents that suppress transcription
11/07/2002	US20020165172 Compositions and methods for treating intracellular diseases
11/07/2002	US20020165171 Delivery construct for antisense nucleic acids and methods of use

1 ... 2666 2667 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 ... 4023